Anticholinergic Drug Use on Admission and the Risk of In-Hospital Falls in Older Hospitalized Patients

References

• Khow KSF, Visvanathan R. Falls in the aging population. Clin Geriatr Med. 2017;33(3):357–368. doi:10.1016/j.cger.2017.03.002
   PubMed Web of Science ®Google Scholar
• Loke MY, Yen Gan LL, Islahudin F. Awareness of medication related falls and preferred interventions among the elderly. Pak J Pharm Sci. 2018;31(2):359–364.
   PubMed Web of Science ®Google Scholar
• Schwendimann R, Buhler H, De Geest S, Milisen K. Characteristics of hospital inpatient falls across clinical departments. Gerontology. 2008;54(6):342–348. doi:10.1159/000129954
   PubMed Web of Science ®Google Scholar
• Krauss MJ, Nguyen SL, Dunagan WC, et al. Circumstances of patient falls and injuries in 9 hospitals in a Midwestern healthcare system. Infect Control Hosp Epidemiol. 2007;28(5):544–550. doi:10.1086/513725
   PubMed Web of Science ®Google Scholar
• Sato N, Hase N, Osaka A, Sairyo K, Katoh S. Falls among hospitalized patients in an acute care hospital: analyses of incident reports. J Med Invest. 2018;65(1.2):81–84. doi:10.2152/jmi.65.81
   PubMed Web of Science ®Google Scholar
• Deandrea S, Bravi F, Turati F, Lucenteforte E, La Vecchia C, Negri E. Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr. 2013;56(3):407–415. doi:10.1016/j.archger.2012.12.006
   PubMed Web of Science ®Google Scholar
• Mazur K, Wilczynski K, Szewieczek J. Geriatric falls in the context of a hospital fall prevention program: delirium, low body mass index, and other risk factors. Clin Interv Aging. 2016;11:1253–1261. doi:10.2147/CIA.S115755
   PubMed Web of Science ®Google Scholar
• Ambrose AF, Paul G, Hausdorff JM. Risk factors for falls among older adults: a review of the literature. Maturitas. 2013;75(1):51–61. doi:10.1016/j.maturitas.2013.02.009
   PubMed Web of Science ®Google Scholar
• Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int. 2012;12(3):425–430. doi:10.1111/j.1447-0594.2011.00783.x
   PubMed Web of Science ®Google Scholar
• Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. 2015;44(1):90–96. doi:10.1093/ageing/afu141
   PubMed Web of Science ®Google Scholar
• de Vries M, Seppala LJ, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs. J Am Med Dir Assoc. 2018;19(4):371 e371–371 e379. doi:10.1016/j.jamda.2017.12.013
   Web of Science ®Google Scholar
• Seppala LJ, Wermelink A, de Vries M, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371 e311–371 e317.
   Web of Science ®Google Scholar
• Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-Risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc. 2018;19(4):372 e371–372 e378.
   Web of Science ®Google Scholar
• Ruxton K, Woodman RJ, Mangoni AA. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2015;80(2):209–220. doi:10.1111/bcp.12617
   PubMed Web of Science ®Google Scholar
• Collamati A, Martone AM, Poscia A, et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res. 2016;28(1):25–35. doi:10.1007/s40520-015-0359-7
   PubMed Web of Science ®Google Scholar
• Lopez-Alvarez J, Sevilla-Llewellyn-Jones J, Anticholinergic A-OL. Drugs in geriatric psychopharmacology. Front Neurosci. 2019;13:1309. doi:10.3389/fnins.2019.01309
   PubMed Web of Science ®Google Scholar
• Vidal X, Agusti A, Vallano A, et al. Elderly patients treated with psychotropic Medicines admitted to hospital: associated characteristics and inappropriate use. Eur J Clin Pharmacol. 2016;72(6):755–764. doi:10.1007/s00228-016-2032-2
   PubMed Web of Science ®Google Scholar
• Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15(6):753–768. doi:10.1517/14740338.2016.1165664
   PubMed Web of Science ®Google Scholar
• Dauphinot V, Faure R, Omrani S, et al. Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort. J Clin Psychopharmacol. 2014;34(5):565–570. doi:10.1097/JCP.0000000000000195
   PubMed Web of Science ®Google Scholar
• Landi F, Dell’Aquila G, Collamati A, et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc. 2014;15(11):825–829. doi:10.1016/j.jamda.2014.08.002
   PubMed Web of Science ®Google Scholar
• Fraser LA, Adachi JD, Leslie WD, et al. Effect of anticholinergic medications on falls, fracture risk, and bone mineral density over a 10-year period. Ann Pharmacother. 2014;48(8):954–961. doi:10.1177/1060028014535363
   PubMed Web of Science ®Google Scholar
• Suehs BT, Caplan EO, Hayden J, Ng DB, Gaddy RR. The relationship between anticholinergic exposure and falls, fractures, and mortality in patients with overactive bladder. Drugs Aging. 2019;36(10):957–967. doi:10.1007/s40266-019-00694-5
   PubMed Web of Science ®Google Scholar
• Egberts A, van der Craats ST, van Wijk MD, Alkilabe S, van den Bemt P, Mattace-Raso FUS. Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients. Pharmacol Res Perspect. 2017;5(3):e00310. doi:10.1002/prp2.310
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–513. doi:10.1001/archinternmed.2007.106
   PubMedGoogle Scholar
• Campbell N, Maidment I, Fox C, Khan B, Boustani M. The 2012 update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc. 2013;61:S142–S143.
   Web of Science ®Google Scholar
• Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56(7):1333–1341. doi:10.1111/j.1532-5415.2008.01737.x
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–787. doi:10.1001/archinte.167.8.781
   PubMedGoogle Scholar
• Machado-Duque ME, Castano-Montoya JP, Medina-Morales DA, Castro-Rodriguez A, Gonzalez-Montoya A, Machado-Alba JE. Drugs with anticholinergic potential and risk of falls with hip fracture in the elderly patients: a case-control study. J Geriatr Psychiatry Neurol. 2018;31(2):63–69. doi:10.1177/0891988718757370
   PubMed Web of Science ®Google Scholar
• Zia A, Kamaruzzaman S, Myint PK, Tan MP. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas. 2016;84:32–37. doi:10.1016/j.maturitas.2015.10.009
   PubMed Web of Science ®Google Scholar
• Squires P, Pahor M, Manini TM, Vouri S, Brown JD. Impact of anticholinergic medication burden on mobility and falls in the lifestyle interventions for elders (LIFE) study. J Clin Med. 2020;9(9):2989. doi:10.3390/jcm9092989
   PubMed Web of Science ®Google Scholar
• Oliver D, Britton M, Seed P, Martin FC, Hopper AH. Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: case-control and cohort studies. BMJ. 1997;315(7115):1049–1053. doi:10.1136/bmj.315.7115.1049
   PubMed Web of Science ®Google Scholar